Chromium Cr-51 API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Chromium Cr-51 API 14392-02-0?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Chromium Cr-51. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Chromium Cr-51
- Synonyms:
- Chromium (51 Cr) , Chromium Cr 51 , Chromium-51
- Cas Number:
- 14392-02-0
- DrugBank number:
- DB11140
- Unique Ingredient Identifier:
- 9QAU17N705
General Description:
Chromium Cr-51, identified by CAS number 14392-02-0, is a notable compound with significant therapeutic applications. Chromium Cr-51 is an isotope of chromium that has been used as a radioactive label for decades. It is used as a diagnostic radiopharmaceutical agent in nephrology to determine glomerular filtration rate, and in hematology to determine red blood cell volume or mass, study the red blood cell survival time and evaluate blood loss.
Half-life:
The half-life of Chromium Cr-51 is an important consideration for its dosing schedule: Chromium Cr-51 has a physical half-life of 27.7 days. This determines the duration of action and helps in formulating effective dosing regimens.
Mechanism of Action:
Chromium Cr-51 functions by: There is evidence that chromium binds to the globin moiety of hemoglobin. This mechanism highlights the drug's role in inhibiting or promoting specific biological pathways, contributing to its therapeutic effects.
Classification:
Chromium Cr-51 belongs to the class of inorganic compounds known as homogeneous transition metal compounds. These are inorganic compounds containing only metal atoms,with the largest atom being a transition metal atom, classified under the direct parent group Homogeneous transition metal compounds. This compound is a part of the Inorganic compounds, falling under the Homogeneous metal compounds superclass, and categorized within the Homogeneous transition metal compounds class, specifically within the None subclass.
Categories:
Chromium Cr-51 is categorized under the following therapeutic classes: Chromium Isotopes, Elements, Isotopes, Metals, Metals, Heavy, Radioisotopes, Transition Elements. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Chromium Cr-51 is a type of Diagnostic agents
Diagnostic agents are a crucial category of pharmaceutical active pharmaceutical ingredients (APIs) used in the field of medical diagnostics. These agents play a vital role in diagnosing various diseases and conditions by aiding in the visualization and identification of specific biomarkers or structures within the body.
Diagnostic agents encompass a wide range of substances, including contrast agents, radiopharmaceuticals, and imaging agents. Contrast agents are commonly used in medical imaging techniques such as X-rays, magnetic resonance imaging (MRI), and computed tomography (CT) scans. They enhance the visibility of certain tissues or organs, allowing healthcare professionals to detect abnormalities more accurately.
Radiopharmaceuticals are another type of diagnostic agent that combines a radioactive component with a pharmaceutical compound. These agents emit radiation that can be detected by specialized imaging equipment, enabling the visualization of metabolic processes and the identification of abnormal cellular activity.
Imaging agents are designed to target specific molecular structures or biomarkers within the body. They can be used to detect and visualize specific proteins, enzymes, or receptors associated with certain diseases or conditions. By targeting these specific biomarkers, imaging agents provide valuable information about the presence, location, and extent of a disease, aiding in diagnosis and treatment planning.
Overall, diagnostic agents are essential tools in modern medicine, facilitating accurate and timely diagnoses. These pharmaceutical APIs enable healthcare professionals to identify and monitor diseases at an early stage, leading to better patient outcomes and improved treatment strategies.
